De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal

NCT05808192 · clinicaltrials.gov ↗

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Single Transplant
5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend IS

Interventions

DRUG: Immunosuppressive

Sponsor

University of Rome Tor Vergata